Dopamine D2 receptor upregulation in dorsal striatum in the LRRK2-R1441C rat model of early Parkinson's disease revealed by in vivo PET imaging.
Delgado-Goñi T. et al, (2025), Sci Rep, 15
An axonal brake on striatal dopamine output by cholinergic interneurons.
Zhang Y-F. et al, (2025), Nat Neurosci
Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes.
Stedehouder J. et al, (2024), Nat Commun, 15
Psychosis as a disorder of muscarinic signalling: psychopathology and pharmacology.
McCutcheon RA. et al, (2024), Lancet Psychiatry, 11, 554 - 565
Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes
Stedehouder J. et al, (2024)
Lights, fiber, action! A primer on in vivo fiber photometry.
Simpson EH. et al, (2024), Neuron, 112, 718 - 739
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.
Brimblecombe KR. et al, (2024), Eur J Neurosci, 59, 1242 - 1259
Axo-glial interactions between midbrain dopamine neurons and oligodendrocyte lineage cells in the anterior corpus callosum.
Caldwell M. et al, (2023), Brain Struct Funct, 228, 1993 - 2006
Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction.
Christie LA. et al, (2023), J Med Chem, 66, 11718 - 11731
Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2.
Kosillo P. et al, (2022), Elife, 11
Dopamine Release in Nucleus Accumbens Is under Tonic Inhibition by Adenosine A1 Receptors Regulated by Astrocytic ENT1 and Dysregulated by Ethanol.
Roberts BM. et al, (2022), J Neurosci, 42, 1738 - 1751
Revisiting dopamine-acetylcholine imbalance in Parkinson's disease: Glutamate co-transmission as an exciting partner in crime.
Zhang Y-F. and Cragg SJ., (2021), Neuron, 109, 1070 - 1071
Axonal Modulation of Striatal Dopamine Release by Local γ-Aminobutyric Acid (GABA) Signalling.
Roberts BM. et al, (2021), Cells, 10
Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol.
Threlfell S. et al, (2021), Front Cell Neurosci, 15
GABA uptake transporters support dopamine release in dorsal striatum with maladaptive downregulation in a parkinsonism model.
Roberts BM. et al, (2020), Nat Commun, 11
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease.
Bengoa-Vergniory N. et al, (2020), Nat Commun, 11
Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice.
Pérez-Taboada I. et al, (2020), Mov Disord, 35, 1636 - 1648